Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Concomitant Vaccination With IC51 and HAVRIX
NCT00596271Phase 3Completed
- Sponsor
- Valneva
- Start
- Sep 2005
- Primary completion
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Valneva. Started Sep 2005; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00596271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596271.